ZelleRx Corporation Business: ZelleRx Corporation is a biopharmaceutical company developing cancer treatment products based on its proprietary natural killer (NK) cell line, NK-92. The company has universal product candidates based on this cell line, and will have, upon completion of certain licensing negotiations, additional targeted product candidates against a variety of cancers, potentially creating a portfolio of products that can be used as adjuvant and/or primary therapies for patients with cancer. Website: www.zellerx.com |